Mr. Speaker, the Minister of Industry rammed through drug patent regulation changes late last week which will continue to push up the prices of medications.
Conveniently, when the cabinet decision was announced, Merck Frosst had all their paperwork ready to block a new generic heart drug from entering the market.
What is the link between the industry minister and the pharmaceutical lobby? Why does the industry minister always grant the pharmaceutical industry protections not granted to any other industry at the expense of the health of Canadians?